Henderson, RaymondO'Flaharta, NaoisePatterson, KeithRedmond, Sandra2025-09-242025-09-242024-04https://doi.org/10.5281/zenodo.10884666https://www.lenus.ie/handle/10147/646149The island of Ireland is a premier destination for life and health science (LHS) enterprises, boasting a distinctive blend of skilled professionals, cutting-edge research facilities, and robust collaborations between industry, academia, and healthcare practitioners. The oncology communities across academia and industry within Northern Ireland (NI) and Ireland (IE) are keen to enhance and upscale All-Island collaborative approaches, aspiring to elevate the entire island to global prominence in oncology and allied digital health endeavours. These are the fastest growing areas of the LHS sector, due to the increasing availability of multi-modal data, the development of genomics-driven cancer medicine and the growth in deployment of artificial intelligence (AI). However, little data are available on the number of oncology and allied digital health companies operating on the island of Ireland. Data on the products/services these companies provide, numbers employed, the ecosystem they operate in, and the economic potential are also lacking. These data are necessary to benchmark performance, along with recommendations on how the LHS sector can be enhanced, to ensure that the full health and socioeconomic benefits of the growth in oncology and allied digital health research on the island are realised. As such, Salutem Insights was commissioned by the All-Island Cancer Research Institute (AICRI; www.aicri.org), a crossborder virtual institute involving 10 universities on the island of Ireland and associated stakeholders, who have received funding under InterTradeIreland’s Synergy Programme, to conduct a study to evaluate the current landscape and economic potential of oncology and allied digital health on the island of Ireland, examining this landscape through an all island and cross-border lens, to illuminate opportunities to increase trade and research and development (R&D) across the island. We conducted a comprehensive search to identify all oncology and allied digital health companies, including both indigenous enterprises and multinational corporations, operating on the island of Ireland. Additionally, we examined the oncology and allied digital health support infrastructure, encompassing hospitals, academic and research centres, as well as charitable organisations and spin-outs, to ensure a thorough assessment of the sector.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Oncology. Pathology.CancerDigital healthReport